EUVIMEDEUVIMED entdecken
Crossref

Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation

Dana Dlouha iD, Sarka Chytilova, Jevgenija Vymetalova, Eva Rohlova, Marianna Lukasova, Sarka Novakova, Jaroslav Alois Hubacek iD

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Dana Dlouha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Center, Institute of Clinical and Experimental Medicine, Prague, Czech Republic. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Cell-Free Nucleic Acids, Tissue Donors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: the Ministry of Health of the Czech Republic, the Ministry of Health of the Czech Republic-DRO, Institute for Clinical and Experimental Medicine-IKEM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma circulating donor‐derived cell‐free DNA (ddcfDNA) can be used to noninvasively monitor acute rejection of heart transplants (HTx). This study utilized digital droplet PCR to analyze ddcfDNA concentrations (measured in copies per milliliter) and the fractional abundance (%ddcfDNA) to differentiate between donor and recipient DNA on the basis of single nucleotide polymorphism (SNP) homozygosity. Seventy‐seven patients participated in a study, providing 300 plasma samples. Both markers, mean ddcfDNA (cp/mL) and %ddcfDNA, showed similar decreasing trends following the HTx, ( R 2 < 0.2; p < 0.001). Significantly higher levels of ddcfDNA (cp/mL) and %ddcfDNA were observed during episodes of acute rejection (AR) compared to non‐rejection samples ( p < 0.001). Additionally, antibody‐mediated rejection (AMR) was associated with increased %ddcfDNA levels compared to non‐rejection and to acute cellular rejection samples ( p < 0.001 and p < 0.01). A logistic regression model identified %ddcfDNA as an early predictor of AMR risk 10–19 days post‐heart transplant (odds ratio 158, p < 0.02). Performance analysis established an optimal %ddcfDNA threshold of 0.125% for AMR detection, correctly identifying all patients without subsequent AMR. These findings suggest that early %ddcfDNA measurements post‐HTx can accurately identify individuals unlikely to develop AMR during the first posttransplant year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationGraft RejectionCell-Free Nucleic AcidsTissue DonorsBiomarkersIsoantibodiesHumansMaleFemaleMiddle AgedFollow-Up StudiesPrognosisAdultGraft SurvivalRisk FactorsEarly Diagnosis

Stichwörter der Autor:innen

SNPbiomarkercfDNArejectiontransplantation

Substanzen

Cell-Free Nucleic AcidsBiomarkersIsoantibodies

Autor:innen und Institutionen

  • Experimental Medicine Center, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Data Science, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
  • Cardio Center, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
  • Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Third Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.

ORCID-Profile: Dana Dlouha, Jaroslav Alois Hubacek

Förderung

  • the Ministry of Health of the Czech Republic
  • the Ministry of Health of the Czech Republic-DRO
  • Institute for Clinical and Experimental Medicine-IKEM

Zitieren

APA

Dlouha, D., Chytilova, S., Vymetalova, J., Rohlova, E., Lukasova, M., Novakova, S., & Hubacek, J. A. (2025). Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70209

Vancouver

Dlouha D, Chytilova S, Vymetalova J, Rohlova E, Lukasova M, Novakova S, et al. Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70209

BibTeX
@article{Dlouha2025,
  author = {Dlouha, Dana and Chytilova, Sarka and Vymetalova, Jevgenija and Rohlova, Eva and Lukasova, Marianna and Novakova, Sarka and Hubacek, Jaroslav Alois},
  title = {Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70209}
}
Kostenlos starten →